IdyllaTM: Summary

IdyllaTM

Healthcare, Diagnostics, Molecular Diagnostics, Oncology

IdyllaTM offers fast and actionable molecular testing results, facilitating personalized medicine and improving clinical decision-making.

IdyllaTM is a revolutionary, fully automated system designed for molecular testing, making it easy, fast, and suitable for any laboratory. It provides rapid molecular biomarker results, enabling timely treatment decisions in oncology.

Fully automated molecular testing; Rapid results in only 3 hours; Wide range of oncology tests available; User-friendly for any lab environment

IdyllaTM is most valuable in scenarios requiring quick molecular diagnostics for cancer treatment decisions, such as in oncology clinics and hospitals.

Speed of results allows for quicker treatment decisions; Comprehensive range of tests for various cancers; Ease of use in any laboratory setting

The main strengths of IdyllaTM include its rapid testing capabilities, automation that reduces human error, and a broad portfolio of oncology tests that cater to diverse patient needs.

IdyllaTM positions itself as a leader in the molecular diagnostics market, focusing on speed, automation, and accessibility for personalized medicine.

The target users include oncologists, pathologists, and laboratory technicians who require efficient and reliable molecular testing solutions.

Request demo

• molecular testing

• oncology

• diagnostics

• personalized medicine

THINK IDYLLA™

Innovative, reliable, professional

IdyllaTM stands out in the market due to its fully automated system that delivers molecular testing results in just 3 hours, which is significantly faster than traditional methods.

Biocartis, the company behind IdyllaTM, is committed to revolutionizing molecular testing and improving clinical practices for the benefit of patients and healthcare providers.

2007-01-01

• Nader Donzel

• Rudi Pauwels